Methichit Wattanapanitch
2 Wanglang Rd
Bangkok, 10700, Thailand
Bangkok, 10700, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 01, 2026
Protocol for assessing anti-Siglec-9 antibody-mediated tumor phagocytosis by macrophages using pH-sensitive dyes and flow cytometry.
Journal: STAR protocols
Published: February 18, 2026
Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 29, 2025
Induced pluripotent stem cell-based modeling of hemolytic anemia in patients with compound heterozygous KLF1 mutations reveals defective erythroid differentiation.
Journal: Stem cell research & therapy
Published: August 08, 2025
MicroRNA profiles of four induced pluripotent stem cell lines derived from distinct tissues.
Journal: BMC research notes
Published: February 22, 2025
A pyrimido-indole derivative promotes the differentiation of hematopoietic stem and progenitor cells from human-induced pluripotent stem cells by modulating YAP/Hippo signaling pathway.
Journal: European journal of pharmacology
Published: January 31, 2025
Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers.
Journal: Stem cell research & therapy
Published: August 14, 2024
Development of 2LTRZFP-expressing induced pluripotent stem cells as a potential anti-HIV-1 gene therapy against viral integration.
Journal: Journal of leukocyte biology
Published: June 28, 2024
Last Updated: 09/26/2026